antimicrobial test1
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
---|---|---|---|---|---|
Penicillinase resistant | Dicloxacillin
🗑
|
||||
PCNase resistant | Nafcillin
🗑
|
||||
PCNase resistant | Oxacillin
🗑
|
||||
PCNase resistant | Methicillin
🗑
|
||||
Anti-pseudo PCN | carboxyPCNs
🗑
|
||||
CarboxyPCNs | Ticarcillin, Carbenecillin
🗑
|
||||
Anti-pseudo PCN | ticarcillin
🗑
|
||||
Anti-pseduo PCN | carbenecillin
🗑
|
||||
Anti-pseudo PCN | UreidoPCN
🗑
|
||||
UreidoPCN | piperacillin, mexlocillin
🗑
|
||||
Anti-pseudo PCN | piperacillin
🗑
|
||||
Anti-pseudo PCN | mexlocillin
🗑
|
||||
Augmentin | Ampicillin & clavulonic acid
🗑
|
||||
Zosyn | Piperacillin & taxobactam
🗑
|
||||
2nd gen Cephs | Cefaclor, Cefotoxin, Loracarbef
🗑
|
||||
3rd gen Cephs | Ceftriaxone, Ceftazidime, Cefixime
🗑
|
||||
4th gen Ceph | Cefepime
🗑
|
||||
5th gen Ceph | Ceftaroline
🗑
|
||||
Imipenem | combined w/cilastin
🗑
|
||||
50s | Chloramphenicol
🗑
|
||||
50S | clindamycin
🗑
|
||||
50s | linezolid
🗑
|
||||
50s | macrolides
🗑
|
||||
50s | quinupristin
🗑
|
||||
50s | dalfopristin
🗑
|
||||
macrolide | erthromycin
🗑
|
||||
macrolide | azithromycin
🗑
|
||||
macrolide | clarithromycin
🗑
|
||||
30s | tetracycline
🗑
|
||||
30s | tigecycline
🗑
|
||||
30s | spectinomycin
🗑
|
||||
30s | aminoglycosides
🗑
|
||||
aminoglycoside | streptomycin
🗑
|
||||
aminoglycoside | gentamycin
🗑
|
||||
aminoglycoside | tobramycin
🗑
|
||||
aminoglycoside | amikacin
🗑
|
||||
aminoglycoside | neomycin
🗑
|
||||
fluroquinolones | naladixic acid
🗑
|
||||
fluroquinolones | 'floxins' - Ciprofloxin, Levofloxin, Trovafloxacin
🗑
|
||||
Lipoglycopeptide | dalbavancin
🗑
|
||||
lipoglycopeptide | telavancin
🗑
|
||||
cyclic lipopeptide | daptomycin
🗑
|
||||
tefibazumab | staph antibody
🗑
|
||||
anti-Tb | Isoniazid
🗑
|
||||
anti-TB | rifampin
🗑
|
||||
anti-TB | pyrazinamide
🗑
|
||||
anti-TB | ethambutol
🗑
|
||||
anti-TB | rifabutin
🗑
|
||||
anti-TB | streptomycin
🗑
|
||||
Rifapentine | latent TB
🗑
|
||||
isoniazid | latent TB
🗑
|
||||
mixed amebicide | metronidazole
🗑
|
||||
mixed amebicide | tinadazole
🗑
|
||||
anti-leprosy | sulfones (dapson/sulfoxone)
🗑
|
||||
anti-leprosy | rifampin
🗑
|
||||
MOA PCNs | inhibit transpeptidases, bind PCN-binding proteins, alter configuration of PG layer
🗑
|
||||
PCN drug of choice for | GAS, GBS, T.pallidum
🗑
|
||||
Natural PCN | broad spectrum
🗑
|
||||
Aminopencillins | better Gm-; Gm+ enterococci increasing resistance
🗑
|
||||
causes interstitial nephritis | Methicillin
🗑
|
||||
increases Na overload, platelet dysfunction, hypokalemia | carbenecillin
🗑
|
||||
Beta Lactamase inhibitors | clavulonic acid, sulbactam, taxobactam
🗑
|
||||
uses for beta lactamase inhibitors | hosp acquired pneumo, anaerobes
🗑
|
||||
used for MRSA | vancomycin
🗑
|
||||
not absorbed in GI so good for Cdiff | vancomycin
🗑
|
||||
CNS penetration | vancomycin
🗑
|
||||
causes red man syndrome when used IV | vancomycin
🗑
|
||||
red man syndrome | nonimmunologic histamine release
🗑
|
||||
MOA vancomycin | inhibits prostaglandin biosynthesis a step earlier than PCN and inhibits transpeptidases
🗑
|
||||
uses of vancomycin | ALL G+
🗑
|
||||
MOA cephalosporins | competitive inhibitor of transpeptidase
🗑
|
||||
PCNs | cidal
🗑
|
||||
cephalosporins | cidal
🗑
|
||||
vancomycin | cidal
🗑
|
||||
monobactams | cidal
🗑
|
||||
carbapenems | cidal
🗑
|
||||
1st generation Ceph is more blank than blank | more Gm+ than Gm-
🗑
|
||||
3rd generation ceph is more blank than blank | more Gm- than Gm+
🗑
|
||||
adverse effect of interfering with Vit K dependant clotting | 2nd gen ceph (cefaclor, cefoxitin, Loracarbef)
🗑
|
||||
might be good for pseudomonas | 3rd gen ceph
🗑
|
||||
good CNS penetration | 3rd gen ceph
🗑
|
||||
tx meningitis | 3rd gen cep
🗑
|
||||
tx meningitis | vancomycin
🗑
|
||||
Cefepime | good Gm+ & Gm- coverage
🗑
|
||||
nosocomial pneumonias (pseudomonas) | cefepime
🗑
|
||||
empiric tx for febrile neutropenia | cefepime
🗑
|
||||
ceftaroline | good for community acquired pneumonia
🗑
|
||||
good for MRSA | ceftaroline
🗑
|
||||
1st ceph w/activity against MRSA | ceftaroline
🗑
|
||||
1st drug for CAP since 1998 | ceftaroline
🗑
|
||||
broad spectrum & highly resistant to B lactamases | carbapenems
🗑
|
||||
combined with cilastin | imipenem
🗑
|
||||
cilastin | inhibits kidney enzyme that metabolizes the drug its combined with and protects from toxicity
🗑
|
||||
good for MRSA | ertapenem
🗑
|
||||
good for ESBL organisms | ertapenem
🗑
|
||||
only Gm- | monobactams
🗑
|
||||
used to tx septicemia | monobactams
🗑
|
||||
single B lactam ring not fused with another | aztreonam
🗑
|
||||
all 50s static except for | quinupristin/dalfopristin
🗑
|
||||
chloramphenicol causes | bone marrow depression w/aplastic anemia
🗑
|
||||
chloramphenicol causes | grey baby syndrome
🗑
|
||||
used in Rickettsia | chloramphenicol
🗑
|
||||
used in meningtitis when allergic to PCN, ceph | chloramphenicol
🗑
|
||||
side effect of clindamycin | pseudomembranous c.diff
🗑
|
||||
used when allergic to PCN & ceph | clindamycin
🗑
|
||||
MOA clindamycin | inhibits toxin production by blocking protein synthesis
🗑
|
||||
used in strep pyogenes & staph TSS | clindamycin
🗑
|
||||
Gm+ | clindamycin
🗑
|
||||
side effects of linezolid | bone marrow suppression (thrombocytopenia, anemia & leukopenia)
🗑
|
||||
mostly Gm+ | linezolid
🗑
|
||||
used for HAP, CAP, staph, MRSA, VRE | linezolid
🗑
|
||||
metabolized cyp450 | macrolides
🗑
|
||||
metabolized cyp450 | erythromyc & clarithromycin
🗑
|
||||
causes QT prolongation | macrolides
🗑
|
||||
interaction with anti-epileptics, warfarin, birth control | macrolides
🗑
|
||||
have anti-inflammatory properties | macrolides
🗑
|
||||
inhibit mononuclear cells, reduce superoxide by PMNs, modify release of cytokines, inhibit biofilms | macrolides
🗑
|
||||
binds to 2 separate sites on protein - irreversible | quinupristin/dalfopristin
🗑
|
||||
multi-drug resistant Gm+ cocci | quinupristin/dalfopristin
🗑
|
||||
VRE | static quinupristin/dalfopristin
🗑
|
||||
MSSA, MRSA, S.pyogenes | cidal quinupristin/dalfopristin
🗑
|
||||
metabolized cyp450 | quinupristin/dalfopristin
🗑
|
||||
side effects of quinupristin/dalfopristin | venous irritation
🗑
|
||||
30s | all static
🗑
|
||||
tetracycline | also includes doxycycline
🗑
|
||||
take this 1 hr before or 3hrs after eating | tetracycline
🗑
|
||||
causes photosensitivity, teeth discoloration | tetracycline
🗑
|
||||
monocycline side effects | lupus like reaction, vertigo, arthritis
🗑
|
||||
tigecycline | slow IV infusion
🗑
|
||||
used for MRSA, VRE, ESBL, MDR acinetobacter | tigecycline
🗑
|
||||
NO activity against pseudomonas | tigecycline
🗑
|
||||
spectinomycin | aminocyclitol abx, closely related to aminoglycosides
🗑
|
||||
often used with PCN to facilitate crossing bacterial Cell wall | aminoglycosides
🗑
|
||||
crosses CNS only with meningeal inflammation | aminoglycosides
🗑
|
||||
oldest aminoglycoside | streptomycin
🗑
|
||||
M/C used aminoglycoside | gentamycin
🗑
|
||||
aminoglycoside used for pseudomonas | tobramycin
🗑
|
||||
aminoglycoside with broadest spectrum | amikacin
🗑
|
||||
topical, toxic aminoglycoside | neomycin
🗑
|
||||
aminoglycoside side effects | vestibular, auditory & nephrotoxicity; neuromuscular blockade
🗑
|
||||
Gm- enteric, Tularemia, tersinia pestis | aminoglycosides
🗑
|
||||
Cidal | fluroquinolones
🗑
|
||||
safe high blood levels with oral absorption and good tissue penetration | fluroquinolones
🗑
|
||||
MOA fluorquinolones | inhibit DNA gyrase
🗑
|
||||
good Gm- coverage | fluroquinolones
🗑
|
||||
resistance is developind due to mutation in bacterial DNA | fluroquinolones
🗑
|
||||
Naladixic acid | 1st generation fluroquinolones
🗑
|
||||
side effect fluoroquinilones | tendon rupture & tendinitis
🗑
|
||||
causes c.diff | fluroquinolones
🗑
|
||||
side effects of ciprofloxin | inhibits GABA- and causes seizures in pt with renal insufficiency
🗑
|
||||
used for chronic bone infxns | fluroquinolones
🗑
|
||||
moxofloxacin | empiric coverage intra-ab infxn & broad spectrum & anaerobes
🗑
|
||||
novel second generation lipoglycopeptide that belongs to same class as Vancomycin | dalbavancin
🗑
|
||||
not yet FDA approved | dalbavancin
🗑
|
||||
for hospital pt with difficult to tx MRSA | dalbavancin
🗑
|
||||
telavancin | also a lipoglycopeptide
🗑
|
||||
MOA telavancin | dual action - inhibits cell wall synthesis & dissipates cell membrane potential
🗑
|
||||
qualified infectious disease product | used @ instutions with a specialist - telavancin
🗑
|
||||
tefibazumab | monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A
🗑
|
||||
daptomycin | newer class of cyclic lipopeptide
🗑
|
||||
causes rapid depolarization Gm+ cell membrane potential inhibiting bacterial DNA, RNA & protein synthesis | daptomycin
🗑
|
||||
side effect of daptomycin | constipation
🗑
|
||||
potential for myopathy | daptomycin
🗑
|
||||
monitor CPK when on this | daptomycin
🗑
|
||||
broad Gm+ coverage of org resistant to methicillin & vancomycin | daptomycin
🗑
|
||||
used in complicated skin & soft tissue infxn: MRSA, VRE, s.agalactiae | daptomycin
🗑
|
||||
isoniazid MOA | interferes with biosyn of mycolic acid component of cell wall
🗑
|
||||
isoniazid side effects | hepatotoxicity
🗑
|
||||
can induce pyridoxine deficiency (Vit B6), causing pellagra manifested by peripheral neuritis, rash & anemia | isoniazid
🗑
|
||||
rifampin MOA | inhibits DNA-dependent RNA polymerase
🗑
|
||||
rifampin side effects | jaundice, red/orange sweat, urine, tears
🗑
|
||||
used for TB & leprosy | rifampin
🗑
|
||||
prophylaxis for exposure to N. meningitides | rifampin
🗑
|
||||
induces p450 | rifampin
🗑
|
||||
pyrazinamide | causes hepatotoxic, gout
🗑
|
||||
ethambutol | crosses BBB
🗑
|
||||
visual disturbance side effects | ethambutol
🗑
|
||||
only 1st line TB that is bacterostatic | ethambutol
🗑
|
||||
rifabutin MOA | inhibits DNA-dependent RNA polymerase
🗑
|
||||
side effects rifabutin | uveitis, orange urine, sweat, tears
🗑
|
||||
used in combo for prevention & tx M. avium or M. intracellulare | rifabutin
🗑
|
||||
increases drug interactions with heart therapy | rifapentine & inh (drugs for latent TB)
🗑
|
||||
take for 3 months | rifapentine & INH
🗑
|
||||
take for 9 months | INH only
🗑
|
||||
sulfonamides MOA | competitive inhibition DHPS which converts PABA in folate synthesis (important for DNA synthesis) therfore bacteriostatic
🗑
|
||||
sulfonamides | no toxicity
🗑
|
||||
diuretics, sulfonlylureas & acetazolamide | sulfa moity also present so beware sulfa allergy
🗑
|
||||
sulfonamides side effects | steven-johnson syndrome, severe sun burn
🗑
|
||||
used to treat UTIs, otitis media, sinusitis, bronchitis, MRSA | sulfonamides
🗑
|
||||
topical silver sulfadiazine | tx burns
🗑
|
||||
sulfadiazine | protect ppl w/RF from infx; tx toxoplasmosis
🗑
|
||||
sulfasalazine | anti-inflammatory agent
🗑
|
||||
metronidazole MOA | binds proteins & DNA - cell death
🗑
|
||||
severe GI side effects | metronidazole
🗑
|
||||
severe CNS depression in elderly side effects | metronidazole
🗑
|
||||
drug of choice for psudomembranous colitis caused by Gm+ cdiff | metronidazole
🗑
|
||||
tinidazole | shorter course of tx than the other amebicide
🗑
|
||||
Leprosy | hansens disease
🗑
|
||||
lepromatous leprosy | low cell-mediated immunity
🗑
|
||||
lepromatous leprosy | organisms everywhere, skin, nevers, eyes, testes
🗑
|
||||
lepromatous leprosy | leonine facies, saddle nose, peripheral neuropathy, digit absorption, blindness, infertility in men
🗑
|
||||
tuberculoid leprosy | intact cell-mediated immunity
🗑
|
||||
tuberculoid leprosy | difficult to isolate from skin or blood
🗑
|
||||
tuberculoid leprosy | skin & nerves involved (1-2 superficial unilateral lesions)
🗑
|
||||
most common cause of neuropathy worldwide | leprosy
🗑
|
||||
Daptomycin | no activity against Gm-
🗑
|
||||
becomes inactivated by pulmonary surfactant therefore not appropriate for pneumonia | daptomycin
🗑
|
||||
methods to figure out MIC | dilution method & disc diffusion method
🗑
|
||||
Bacteriocidal | have MBC similar to MIC
🗑
|
||||
bacteriostatic | have MBC higher than MIC
🗑
|
||||
stronger ABX | have very low MICs
🗑
|
||||
MIC of resistant org | >2
🗑
|
||||
four pharmacokinetic processes | absorption, distribution, metabolism, excretion
🗑
|
||||
pharmacokinetics | how much of drug arrives at destination to have an effect
🗑
|
||||
pharmacokinetics | determines time course of drug response & appropriate dosing strategies
🗑
|
||||
pharmacodynamics | drug receptor interaction, pt functional status, placebo
🗑
|
||||
pharmacodynamics | determines the nature & intensity of the response
🗑
|
||||
pharmacodynamic/pharmacokinetic drug activity ration | PD/PK: takes into account the peak drug CONCENTRATION & length of TIME of drug exposure at site of infection - it is time/concentration!!
🗑
|
||||
who produces beta lactamase | H. flu, M.catarrhalis, anaerobic bacteria, gonorrhea also now
🗑
|
||||
B-lactamase production | binding is irreversible & cannot be overcome with higher dosing but CAN BE OVERCOME WITH B-LACTAMASE INHIBITORS
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
jjohrden16
Popular Science sets